FDA Approves Drugs to Treat Internal Contamination from Radioactive Elements

From: The Journal of Nuclear Medicine | Date: October 1, 2004| Author: Anonymous | Copyright information

The Food and Drug Administration (FDA) announced on August 11 the approval of two drugs, pentetate calcium trisodium injection (Ca-DTPA) and pentetate zinc trisodium injection (Zn-DTPA) for treating radiation contamination involving plutonium, americium, or curium. The 2 drugs have been used for several decades as investigational drugs to treat patients in radiation contamination emergencies. The FDA noted in the announcement that Ca-DTPA and Zn-DTPA should not be administered simultaneously....